Marina Chiara Garassino to Deoxycytidine
This is a "connection" page, showing publications Marina Chiara Garassino has written about Deoxycytidine.
Connection Strength
0.185
-
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2021 10; 22(10):1438-1447.
Score: 0.185